GLP-1 Medications for PCOS

Why PCOS & GLP-1s Are a Good Match

PCOS (Polycystic Ovary Syndrome) is strongly linked to insulin resistance — the same metabolic issue GLP-1 drugs are designed to address. Up to 70% of women with PCOS have insulin resistance, which drives many of the condition's symptoms.

GLP-1 agonists improve insulin sensitivity, reduce androgen levels, promote weight loss, and may help restore more regular ovulation.

What Research Shows

• Multiple small trials show semaglutide outperforms metformin for weight loss in women with PCOS
• Studies show reductions in testosterone and LH/FSH ratios (key PCOS hormones)
• Many women report more regular periods within 3–6 months
• Improvements in acne and hirsutism (excess hair) have been reported

Is It FDA-Approved for PCOS?

No — GLP-1 drugs are not FDA-approved specifically for PCOS. However, they are frequently prescribed off-label for this purpose. If you have PCOS and meet criteria for obesity or Type 2 diabetes, insurance coverage may be available.

Fertility Considerations

Important: GLP-1 drugs should be stopped at least 2 months before trying to conceive and are not recommended during pregnancy. If improved fertility is a goal, discuss timing carefully with your OB-GYN or reproductive endocrinologist.